Literature DB >> 22176921

Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis.

P Fogelstrand1, J Borén.   

Abstract

AIMS: In this review, we discuss the mechanisms behind the binding of low-density lipoproteins (LDL) to the arterial wall and how this interaction might be targeted to prevent atherosclerosis. DATA SYNTHESIS: An increasing body of evidence shows that accumulation of LDL in the vessel wall is a critical step in the development of atherosclerosis. The retained lipoproteins subsequently provoke an inflammatory response that ultimately leads to atherosclerosis. In the arterial wall, LDL binds ionically to proteoglycans in the extracellular matrix. In particular, proteoglycans with elongated glycosaminoglycan (GAG) chains seem to play a crucial role in this process.
CONCLUSIONS: The LDL-proteoglycan interaction is a highly regulated process that might provide new therapeutic targets against cardiovascular disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22176921     DOI: 10.1016/j.numecd.2011.09.007

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  36 in total

1.  Serglycin protects against high fat diet-induced increase in serum LDL in mice.

Authors:  Astri J Meen; Christian A Drevon; Gunnar Pejler; Trond G Jenssen; Ole Kristoffer Olstad; Magnus Åbrink; Svein O Kolset
Journal:  Glycoconj J       Date:  2015-09-21       Impact factor: 2.916

2.  Macrophages, extracellular matrix, and lipoproteins in arterial cholesterol balance.

Authors:  Germán Camejo; Eva Hurt-Camejo
Journal:  J Lipid Res       Date:  2013-11-19       Impact factor: 5.922

3.  Kinetic analysis of thermal stability of human low density lipoproteins: a model for LDL fusion in atherogenesis.

Authors:  Mengxiao Lu; Donald L Gantz; Haya Herscovitz; Olga Gursky
Journal:  J Lipid Res       Date:  2012-07-31       Impact factor: 5.922

Review 4.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

5.  Pathway analysis with next-generation sequencing data.

Authors:  Jinying Zhao; Yun Zhu; Eric Boerwinkle; Momiao Xiong
Journal:  Eur J Hum Genet       Date:  2014-07-02       Impact factor: 4.246

6.  CAV1-CAVIN1-LC3B-mediated autophagy regulates high glucose-stimulated LDL transcytosis.

Authors:  Xiangli Bai; Xiaoyan Yang; Xiong Jia; Yueguang Rong; Lulu Chen; Tianshu Zeng; Xiuling Deng; Wenjing Li; Guangjie Wu; Ling Wang; Ye Li; Jing Zhang; Zhifan Xiong; Liang Xiong; Yumei Wang; Lin Zhu; Ying Zhao; Si Jin
Journal:  Autophagy       Date:  2019-09-04       Impact factor: 16.016

Review 7.  Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?

Authors:  Pedro Valdivielso; José Ramírez-Bollero; Carmen Pérez-López
Journal:  World J Diabetes       Date:  2014-10-15

8.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

9.  Binding to heparin triggers deleterious structural and biochemical changes in human low-density lipoprotein, which are amplified in hyperglycemia.

Authors:  Shobini Jayaraman; Olivia R Chavez; Antonio Pérez; Inka Miñambres; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-04-11       Impact factor: 4.698

10.  The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.

Authors:  Tixieanna Dissmore; Cheikh I Seye; Denis M Medeiros; Gary A Weisman; Barry Bradford; Laman Mamedova
Journal:  Atherosclerosis       Date:  2016-07-29       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.